This is a test post

This is a test article without using elementor Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Donec odio. Quisque volutpat mattis eros. Nullam malesuada erat ut turpis. Suspendisse urna nibh, viverra non, semper suscipit, posuere a, pede. Donec nec justo…

BRIM Biotechnology, Inc. raises $20 million in Series E funding round

Taipei, Taiwan, 1st December 2022 / BRIM Biotechnology, Inc. (“BRIM,” TPEx 6885), a clinical-stage biotechnology company advancing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases, announced today that it has raised $20 million in its Series E funding…

BRIM team chart

A Team Approach to Translational Science

Success doesn’t just come from a winning idea or an exciting new concept.  Success comes from having a dedicated team behind that idea, with the enthusiasm and commitment to drive it from concept to clinic. The people behind the peptide…

Download BRIM's Corporate Overview

This site is registered on as a development site.